Ryan Hsi, MD
Urology · Orange, CANPI 1043451073
Payments from drug & device makers
Across 26 payments — averaging $183.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KARL Storz Endoscopy-america$2K
- KARL Storz Lithotripsy-america$1K
- Urogen Pharma, Inc.$770
- C. R. Bard, Inc. & Subsidiaries$625
- Boston Scientific$436
- Dornier Medtech America, Inc$130
What the payments were for
- Consulting fees$1,10123%
- Travel & lodging$2,51553%
- Food & beverage$1,08623%
- Education$661%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KARL Storz Endoscopy-america | 9 | $1,719 |
| KARL Storz Lithotripsy-america | 4 | $1,088 |
| Urogen Pharma, Inc. | 1 | $770 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $625 |
| Boston Scientific | 6 | $436 |
| Dornier Medtech America, Inc | 3 | $130 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEPHROSCOPE MIP M$1,141
- URETERO-RENO-FIBERSCOPE FLEX-X$901
- JELMYTO$770
- GENERAL - THERAPIES$340
- TRADE - 11278VSU FLEXC F/ACMI-OLYMPUS$316
- Bard Urinary Drainage Bag$294
- 16 FR. FLEXIBLE VIDEO CYSTOSCOPE$108
- CYSTOSCOPE-URETHROSCOPE SHEATH ONLY,22FR$104
How this compares
$4,768 in reported general payments places this provider in the 60th percentile of 1,324 urology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Thiola EcTiopronin | 20 | $98,927 |
| MyrbetriqMirabegron | 15 | $10,174 |
| Potassium Citrate ErPotassium Citrate | 80 | $8,863 |
| Estradiol | 18 | $1,219 |
| Trospium Chloride | 24 | $1,059 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 62 | $650 |
| Potassium Chloride | 28 | $614 |
| Indapamide | 39 | $509 |
| Tamsulosin Hcl | 58 | $424 |
| Chlorthalidone | 13 | $326 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $273 |
| Cefdinir | 21 | $252 |
| Allopurinol | 12 | $140 |
| Ciprofloxacin Hcl | 19 | $75 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $75 |
Paid to pharmacies, not to this prescriber.
Other urology in Orange
- Edward UchioOrange$21.1M
- Ralph ClaymanOrange$3.9M
- Jaime LandmanOrange$851K
- Faysal YafiOrange$346K
- Stephen FreedlandWest Hollywood$16.7M
- Alec KooTorrance$7.4M
- Karim ChamieLos Angeles$4.3M
- Siamak DaneshmandLos Angeles$3.5M
- Arnold ChinLos Angeles$3.5M
- Roger LiLoma Linda$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.